Key result
Elderly patients with depression had significantly higher serum levels of sICAM-1 (674.94 vs 467.05 ng/ml, p<0.01) and sVCAM-1 (572.14 vs 449.04 ng/ml, p<0.05) compared to healthy controls.
Why the study?
Are serum levels of soluble adhesion molecules (sICAM-1 and sVCAM-1) elevated in elderly individuals with late-life depression compared to matched controls?
Case-Control (n=66)
Are serum levels of soluble adhesion molecules (sICAM-1 and sVCAM-1) elevated in elderly individuals with late-life depression compared to matched controls?
Absolute Event Rate: 674.94% vs 467.05%
p-value: p=<0.01
Late-life depression is associated with elevated levels of soluble adhesion molecules (sICAM-1 and sVCAM-1), supporting the vascular depression hypothesis.
Supports vascular depression hypothesis; hypothesis-generating and should not change practice pending prospective validation.
OBJECTIVES: Late-life depression may be associated with vascular disease. The purpose of the study was to investigate this association by determining the levels of soluble adhesion molecules (sICAM-1 and sVCAM-1) which represent markers of ischemia-induced inflammation in elderly individuals with depression. METHODS: Blood samples were obtained from 33 subjects with depression selected from a community-dwelling population after screening with the Geriatric Depression Scale, and 33 matched controls. Serum concentrations of sICAM-1 (ng/mL) and sVCAM-1 (ng/mL) were measured in both groups. RESULTS: Depressed patients (Group A) possessed significantly higher sICAM-1 levels compared to healthy controls (Group B) (674.94 +/- 166.90 ng/ml vs 467.05 +/- 231.26 ng/ml, respectively, p < 0.01). Similarly the same groups demonstrated elevated sVCAM-1 levels compared to controls (572.14 +/- 182.20 ng/ml vs 449.04 +/- 285.27 ng/ml, p < 0.05); a difference that in both cases remained significant after adjustment for potential confounders (gender, smoking, presence of metabolic syndrome). CONCLUSION: These findings indicate an association between high serum levels of VCAM-1, and ICAM-1 and depression in the elderly and further support the vascular depression hypothesis, which has important implications for the understanding and management of late-life depression.
No takes yet. Share an insight, caveat, or question.
Dimopoulos et al. (2006) conducted a case-control in Late-life depression (n=66). Depression vs. Matched healthy controls was evaluated on Serum concentration of sICAM-1 (ng/mL) (p=<0.01). Elderly patients with depression had significantly higher serum levels of sICAM-1 (674.94 vs 467.05 ng/ml, p<0.01) and sVCAM-1 (572.14 vs 449.04 ng/ml, p<0.05) compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: